US Stock MarketDetailed Quotes
EPIX ESSA Pharma
- 6.040
- -0.010-0.17%
Close Oct 4 16:00 ET
267.99MMarket Cap-9741P/E (TTM)
6.340High5.850Low42.42KVolume6.050Open6.050Pre Close257.97KTurnover0.17%Turnover RatioLossP/E (Static)44.37MShares11.67052wk High2.08P/B151.96MFloat Cap2.67052wk Low--Dividend TTM25.16MShs Float245.000Historical High--Div YieldTTM8.10%Amplitude1.400Historical Low6.081Avg Price1Lot Size
ESSA Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -17.11%-5.75M | -13.43%-6.82M | -55.06%-6.79M | 29.35%-19.78M | 39.97%-4.49M | 22.34%-4.91M | 28.32%-6.01M | 24.79%-4.38M | -10.17%-28M | -1.27%-7.48M |
| Net income from continuing operations | 0.89%-7.23M | -27.33%-8.99M | 11.53%-5.96M | 24.27%-26.58M | 13.32%-5.48M | 17.31%-7.3M | 34.96%-7.06M | 25.90%-6.74M | 4.62%-35.1M | 26.12%-6.32M |
| Operating gains losses | -130.07%-278.8K | 152.72%281.61K | -479.14%-418.51K | 97.29%-528 | 29,638.32%81.48K | -480.43%-121.18K | 190.61%111.43K | -158.24%-72.26K | 74.28%-19.51K | 100.05%274 |
| Depreciation and amortization | -25.56%22.67K | -27.07%22.21K | -24.44%23.01K | -2.71%118.49K | -10.83%27.15K | 0.00%30.45K | 0.00%30.45K | 0.00%30.45K | 11.26%121.79K | 5.72%30.45K |
| Other non cash items | 470.07%8.71K | 371.50%9.17K | 185.15%6.7K | 104.16%7.32K | 102.41%1.5K | -95.79%1.53K | 101.69%1.94K | 106.70%2.35K | -164.58%-175.91K | -112.39%-62.15K |
| Change In working capital | -140.58%-618.82K | 376.04%946.64K | -211.26%-1.04M | 399.89%2.34M | 107.63%225.53K | 98.68%1.52M | -145.81%-342.94K | 41.44%931.75K | -140.07%-780.01K | -175.02%-2.95M |
| -Change in receivables | 125.37%31.58K | -690.01%-34.56K | -440.44%-45.55K | -126.69%-128.85K | -113.32%-1.76K | -1,815.54%-124.51K | 120.68%5.86K | -101.67%-8.43K | 406.39%482.8K | 105.05%13.24K |
| -Change in prepaid assets | -104.98%-18.59K | -13.99%374.33K | -413.15%-983.07K | 236.49%1.23M | 108.84%110.17K | -24.68%373.11K | -36.29%435.21K | -27.72%313.93K | 164.99%366.26K | 27.06%-1.25M |
| -Change in payables and accrued expense | -147.92%-611.58K | 181.27%637.2K | -96.45%22.26K | 175.85%1.24M | 106.80%117.13K | 358.12%1.28M | -936.13%-784.01K | 323.70%626.25K | -161.07%-1.63M | -291.93%-1.72M |
| -Change in other current liabilities | ---20.23K | ---30.34K | ---30.34K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -17.11%-5.75M | -13.43%-6.82M | -55.06%-6.79M | 29.35%-19.78M | 39.97%-4.49M | 22.34%-4.91M | 28.32%-6.01M | 24.79%-4.38M | -10.17%-28M | -1.27%-7.48M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 102.64%23.49K | 7,226.00%62.51M | 650.98%8.23M | 93.35%-3.53M | 92.10%-264.65K | 92.62%-891.15K | 96.71%-877.19K | 86.42%-1.49M | -51.52%-53.05M | -3.35M |
| Net investment purchase and sale | 102.64%23.49K | 7,226.00%62.51M | 650.98%8.23M | 93.35%-3.53M | 92.10%-264.65K | 92.62%-891.15K | 96.70%-877.19K | 86.43%-1.49M | -51.47%-53.05M | -29,430.60%-3.35M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 102.64%23.49K | 7,226.00%62.51M | 650.98%8.23M | 93.35%-3.53M | 92.10%-264.65K | 92.62%-891.15K | 96.71%-877.19K | 86.42%-1.49M | -51.52%-53.05M | ---3.35M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 172.00%25.58K | 1,958.03%643.6K | 1,156.45%196.66K | -126.97%-68.16K | 60.60%-13.65K | -820.82%-35.52K | -118.91%-34.64K | -84.24%15.65K | -99.82%252.74K | -359.99%-34.64K |
| Net issuance payments of debt | --0 | --0 | --0 | -2.12%-136.87K | 7.43%-32.07K | -2.55%-35.52K | -7.00%-34.64K | -7.00%-34.64K | -33.65%-134.02K | -13.03%-34.64K |
| Proceeds from stock option exercised by employees | --25.58K | --643.6K | 291.04%196.66K | -82.23%68.71K | --18.42K | --0 | --0 | -61.81%50.29K | -70.71%386.76K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 172.00%25.58K | 1,958.03%643.6K | 1,156.45%196.66K | -126.97%-68.16K | 60.60%-13.65K | -820.82%-35.52K | -118.91%-34.64K | -84.24%15.65K | -99.82%252.74K | -359.99%-34.64K |
| Net cash flow | ||||||||||
| Beginning cash position | 106.96%91.68M | -31.00%35.34M | -40.95%33.7M | -58.59%57.08M | -43.32%38.47M | -48.63%44.3M | -57.69%51.22M | -58.59%57.08M | 144.71%137.83M | -53.26%67.87M |
| Current changes in cash | 2.34%-5.7M | 913.78%56.33M | 128.05%1.64M | 71.07%-23.38M | 56.11%-4.77M | 68.29%-5.83M | 80.12%-6.92M | 64.98%-5.86M | -199.07%-80.8M | -47.35%-10.86M |
| Effect of exchange rate changes | -38.41%-1.9K | 55.48%4.08K | 201.86%438 | -95.20%2.46K | -97.60%1.64K | -105.67%-1.37K | -52.08%2.63K | 99.08%-430 | 191.38%51.28K | 8,360.37%68.11K |
| End cash Position | 123.53%85.99M | 106.96%91.68M | -31.00%35.34M | -40.95%33.7M | -40.95%33.7M | -43.32%38.47M | -48.63%44.3M | -57.69%51.22M | -58.59%57.08M | -58.59%57.08M |
| Free cash flow | -17.11%-5.75M | -13.43%-6.82M | -55.06%-6.79M | 29.35%-19.78M | 39.97%-4.49M | 22.34%-4.91M | 28.32%-6.01M | 24.79%-4.38M | -10.17%-28M | -1.27%-7.48M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data